CLINICAL DYNAMICS

Study Name: Prospective, Single-Center, Single-Arm, Open Clinical Study to Evaluate the Safety and Effectiveness of Artificial Cornea for Treating Corneal Diseases Requiring Lamellar Transplantation Surgery in Corneal Transplant Patients
Site: Tongji Medical College, Huazhong University of Science and Technology, Union Hospital
Sponsor: Xiwel (Suzhou) Biomedical Technology Co., Ltd.
HGRAC Approval Time: February 2024

Study Name: Comparative Analysis of Immune Cells in the Tumor Microenvironment of Colorectal Cancer Based on Single-Cell Sequencing
Site: Beijing Cancer Prevention and Research Institute
HGRAC Approval Time: February 2024

Study Name: Evaluation of Embotrap Retrieval and Thrombus Assessment in Cerebrovascular Mechanical Thrombectomy
Site: Xuanwu Hospital, Capital Medical University (Beijing Geriatric Health and Disease Prevention Center, Beijing Institute of Functional Neurosurgery)
Sponsor: Johnson & Johnson Medical Equipment (Shanghai) Co., Ltd., Depuy Synthes Products, Inc.
HGRAC Approval Time: February 2024
Note: HGRAC Approval or Filing (Human Genetic Resource Administration of China) is an important step before the first enrollment of subjects for clinical trials in China sponsored by foreign companies.

Study Name: Clinical Research on Reference Interval Establishment of Thyroglobulin Assay Kit (Chemiluminescence Method)
Site: Beijing Huaxin Hospital (First Affiliated Hospital of Tsinghua University)
Sponsor: Beckman Coulter 
HGRAC Approval Time: February 2024
Note: HGRAC Approval or Filing (Human Genetic Resource Administration of China) is an important step before the first enrollment of subjects for clinical trials in China sponsored by foreign companies.

Study Name: Clinical Study of Human HER2 Gene Amplification Test Kit (Digital PCR Method)
Site: Qingyuan People's Hospital
Sponsor: Shenzhen MedCaptain 
HGRAC Approval Time: February 2024

Study Name: Clinical Study of Helicobacter pylori Nucleic Acid Test Kit (Digital PCR Method)
Site: Qingyuan People's Hospital
Sponsor: Shenzhen MedCaptain 
HGRAC Approval Time: February 2024

Study Name: Artificial Intelligence Methods and Applications in the Diagnosis and Treatment of Breast Cancer in Clinical Settings
Site: Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Third-Party Lab: Sun Yat-sen University, Beiming Software Co., Ltd., City University of Hong Kong
HGRAC Approval Time: January 2024

Study Name: Prospective, Single-Center, Exploratory Study to Evaluate the Feasibility and Safety of Transcatheter Mitral Valve Clip and Delivery System in Treating Moderate to Severe Primary Mitral Regurgitation
Site: The First Hospital of Hebei Medical University
Sponsor: Shanghai MicroPort CardioFlow Medtech 
HGRAC Approval Time: January 2024
Note: HGRAC Approval or Filing (Human Genetic Resource Administration of China) is an important step before the first enrollment of subjects for clinical trials in China sponsored by foreign companies.

Study Name: Study on Physiological-Guided Machine Learning Methods for Precise Typing of Heart Failure with Preserved Ejection Fraction (HFpEF)
Site: Peking University Third Hospital (Peking University Third Clinical Medical College)
Sponsor: University of Michigan
HGRAC Approval Time: January 2024
Note: HGRAC Approval or Filing (Human Genetic Resource Administration of China) is an important step before the first enrollment of subjects for clinical trials in China sponsored by foreign companies.

Study Name: Development and Testing of Flow Cytometer Peripheral Blood Sample Collection Project
Site: Suzhou Science and Technology City Hospital
Sponsor: BD Shanghai
HGRAC Approval Time: January 2024
Note: HGRAC Approval or Filing (Human Genetic Resource Administration of China) is an important step before the first enrollment of subjects for clinical trials in China sponsored by foreign companies.